CenterWell, a provider of healthcare services, completed the acquisition of MaxHealth, adding to its portfolio of personalized care options. The transaction closed on February 13, 2026.

Acquirer:CenterWell (US)
Target:MaxHealth (US)
Deal Value:Undisclosed
Type of Deal:Acquisition
Closing Date:2026-02-13
Buy-Side Advisors:J.P. Morgan Securities, Latham & Watkins, Brownstein Hyatt Farber Schreck

The deal sees CenterWell expanding its reach into new key markets and serving more patients with its unique approach to personalized care.

Deal Mechanics

CenterWell, an established provider of healthcare services in the United States, has completed the acquisition of MaxHealth from Arsenal Capital Partners. The transaction was announced on February 13, 2026, with details remaining undisclosed regarding financial terms and other key specifics.

Strategic Rationale

CenterWell’s strategic rationale for the deal is to enhance its market presence by acquiring MaxHealth’s assets. The acquisition will enable CenterWell to serve a broader patient base and introduce its personalized care model to additional geographic regions, thereby strengthening its position in the healthcare sector.

Financial Context

The specific financial details of the deal, including the purchase price and other key terms, were not disclosed. However, the transaction is expected to support CenterWell’s growth objectives by facilitating access to new markets and patient populations.

Advisors

J.P. Morgan Securities provided investment banking services for CenterWell in this acquisition. Legal counsel was supplied by Latham & Watkins, while Brownstein Hyatt Farber Schreck offered additional legal support.

Outlook

The integration of MaxHealth into the CenterWell portfolio is anticipated to drive further growth and innovation within the healthcare services sector. The combined entity will focus on delivering enhanced patient care through its personalized approach, thereby addressing the evolving needs of consumers in a rapidly changing market.